Literature DB >> 18937976

Persistence of molecular remission throughout pregnancy in CML after imatinib.

Federica Sorà, Silvia De Matteis, Jolanta Bajer, Francesco D'alò, Giuseppe Leone, Simona Sica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18937976     DOI： 10.1016/j.leukres.2008.09.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  2 in total

1.  The impact of dasatinib on pregnancy outcomes.

Authors:  Jorge E Cortes; Elisabetta Abruzzese; Ekaterina Chelysheva; Mausumee Guha; Nicola Wallis; Jane F Apperley
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

Review 2.  Tyrosine kinase inhibitors and pregnancy.

Authors:  Elisabetta Abruzzese; Malgorzata Monika Trawinska; Alessio Pio Perrotti; Paolo De Fabritiis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.